Scipher Medicine Plans Launch of Blood Test to Predict Rheumatoid Arthritis Treatment Response
The molecular test could help identify patients more likely to respond to abatacept, with early access expected in 2027.
The molecular test could help identify patients more likely to respond to abatacept, with early access expected in 2027.
Researchers at JAX and MIT have developed a microneedle patch that samples immune cells from skin within hours, providing a noninvasive alternative to blood draws and biopsies.
From rising demand for comprehensive IgE profiles to the emergence of molecular allergen diagnostics, laboratories are central to how clinicians prepare for and manage September’s asthma spike.
Due to climate change, wilderness encroachment, and better diagnoses, AGS has joined a growing list of both tick-borne & allergic diseases.
Read MoreOne-Sentence Summary:Beckman Coulter Life Sciences has launched a next-generation Basophil...
Read MoreA machine learning algorithm achieved 97% accuracy in diagnosing celiac disease from biopsy images, potentially improving diagnostic speed.
Read MoreThough the most common tick-related infection, Lyme disease is easy to treat, but hard to diagnose. Virax Biolabs is aiming to change that.
Read MoreWerfen’s Aptiva APS IgG and IgM Reagents for antiphospholipid syndrome (APS) diagnosis address a need in autoimmune disease diagnostics.
Read MoreResearchers developed an AI-powered Genetic Progression Score to predict autoimmune disease progression from preclinical stages.
Read MoreExagen added new biomarkers to its AVISE CTD platform, enhancing diagnostic accuracy for SLE and rheumatoid arthritis (RA).
Read MoreAugurex Life Sciences and Quest partnered to introduce the 14-3-3η biomarker-based test for rheumatoid arthritis across the U.S.
Read MoreResearchers identified genes closely linked to both rheumatoid arthritis and osteoporosis, offering diagnostic markers for these diseases.
Read MoreAugurex Life Sciences and ARUP Labs collaborated on a test to detect rheumatoid arthritis for improved early diagnostic capabilities.
Read MoreA mast cell activation test mimics allergic reactions in a test tube, offering a more precise alternative to food allergy diagnostics.
Read MoreALK introduced new FDA-approved AccuTest line of allergy skin testing devices and allergen well trays for allergy testing and diagnosis.
Read MoreDiaCarta secured a contract with the San Francisco VA Health Care System to provide VEXAS syndrome testing for veterans.
Read MoreThermo Fisher’s Phadia Laboratory Systems enhance the precision and speed of diagnosing autoimmune diseases, such as rheumatoid arthritis.
Read MoreACCU Reference Medical Lab launched molecular PCR panels for better diagnosis of tick-borne diseases to provide for better patient outcomes.
Read More